Charge‐Stabilized Nanodiscs as a New Class of Lipid Nanoparticles
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Nanoparticles have the potential to improve disease treatment and diagnosis due to their ability to incorporate drugs, alter pharmacokinetics, and enable tissue targeting. While considerable effort is placed on developing spherical lipid-based nanocarriers, recent evidence suggests that high aspect ratio lipid nanocarriers can exhibit enhanced disease site targeting and altered cellular interactions. However, the assembly of lipid-based nanoparticles into non-spherical morphologies has typically required incorporating additional agents such as synthetic polymers, proteins, lipid-polymer conjugates, or detergents. Here, charged lipid headgroups are used to generate stable discoidal lipid nanoparticles from mixed micelles, which are termed charge-stabilized nanodiscs (CNDs). The ability to generate CNDs in buffers with physiological ionic strength is restricted to lipids with more than one anionic group, whereas monovalent lipids only generate small nanoliposomal assemblies. In mice, the smaller size and anisotropic shape of CNDs promote higher accumulation in subcutaneous tumors than spherical liposomes. Further, the surface chemistry of CNDs can be modified via layer-by-layer (LbL) assembly to improve their tumor-targeting properties over state-of-the-art LbL-liposomes when tested using a metastatic model of ovarian cancer. The application of charge-mediated anisotropy in lipid-based assemblies can aid in the future design of biomaterials and cell-membrane mimetic structures.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Charge‐Stabilized Nanodiscs as a New Class of Lipid Nanoparticles
- Date Crossref
- 14/11/2024
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Massachusetts Institute of Technology Department of Chemical Engineering pays non établi dans la noticeUniversité ou école supérieure
-
Howard Hughes Medical Institute pays non établi dans la noticeStructure de recherche
-
Ragon Institute of MGH pays non établi dans la noticeÉtablissement de santé
-
Koch Institute for Integrative Cancer Research pays non établi dans la noticeStructure de recherche
Department of Chemical Engineering — Massachusetts Institute of Technology, Howard Hughes Medical Institute et Ragon Institute of MGH, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.